These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6105184)

  • 1. On the metabolism of clofibride, a hypolipaemic drug.
    Loiseau GP; Millischer RJ; Lohier PY; Mardiguian JS; Gilede AM; Ginocchio AV
    J Pharm Pharmacol; 1980 Jul; 32(7):483-8. PubMed ID: 6105184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofibrate and clofibric acid: comparison of the metabolic disposition in rats and dogs.
    Cayen MN; Ferdinandi ES; Greselin E; Robinson WT; Dvornik D
    J Pharmacol Exp Ther; 1977 Jan; 200(1):33-43. PubMed ID: 833760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study and bioavailability of three marketed compounds releasing p-chlorophenoxyisobutyric acid (CPIB) in volunteers.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):113-8. PubMed ID: 1002348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state kinetics of bezafibrate and clofibrate in healthy female volunteers.
    Abshagen U; Spörl-Radun S; Marinow J
    Eur J Clin Pharmacol; 1980 Apr; 17(4):305-8. PubMed ID: 6995131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of cholestyramine on the pharmacokinetics of clofibrate in man.
    Sedaghat A; Ahrens EH
    Eur J Clin Invest; 1975 Apr; 5(2):177-85. PubMed ID: 1149779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A quantitative gaschromatographic method for the determination of p-chlorophenoxyisobutyric acid (clofibrinic acid) in human plasma (author's transl)].
    Häselbarth V
    Arzneimittelforschung; 1976; 26(11):2076-80. PubMed ID: 1037251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition and metabolism of flurbiprofen in several species including man.
    Risdall PC; Adams SS; Crampton EL; Marchant B
    Xenobiotica; 1978 Nov; 8(11):691-703. PubMed ID: 103331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent pharmacokinetics of clofibric acid in the non-human primate.
    Walmsley LM
    Arch Toxicol Suppl; 1984; 7():272-7. PubMed ID: 6595991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofibrate pharmacokinetics: effect of elevation of plasma-free fatty acids.
    Crouthamel WG; Cenedella RJ
    Pharmacology; 1975; 13(5):465-73. PubMed ID: 1208648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The physiological disposition of the anti-tussive agent, 1,2,3,4a,9b-hexahydro-8,9b-dimethyl-4-[3-(4-methylpiperazin-1-yl)propionamido]dibenzofuran-3-one dihydrochloride Azipranone, in man, rat, dog and baboon.
    Daniel JW; James GW; Rowlands DA; Taylor JB
    Xenobiotica; 1978 May; 8(5):321-9. PubMed ID: 96617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
    Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
    Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in the metabolic conjugation of clofibric acid and clofibrate in laboratory animals and man.
    Emudianughe TS; Caldwell J; Sinclair KA; Smith RL
    Drug Metab Dispos; 1983; 11(2):97-102. PubMed ID: 6133730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative metabolism of fenclorac in rat, dog, monkey, and man.
    DeLong AF; Smyth RD; Polk A; Nayak RK; Martin G; Douglas GH; Reavey-Cantiwell NH
    Drug Metab Dispos; 1977; 5(2):122-31. PubMed ID: 15804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile.
    Stierlin H; Faigle JW
    Xenobiotica; 1979 Oct; 9(10):611-21. PubMed ID: 119353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical studies with oxitropium bromide. 1. Pharmacokinetics and metabolism in the rat and dog].
    Wahl D; Förster HJ; Pook KH; Richter I
    Arzneimittelforschung; 1985; 35(1A):255-65. PubMed ID: 4039166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism.
    Maurer G; Schreier E; Delaborde S; Nufer R; Shukla AP
    Eur J Drug Metab Pharmacokinet; 1983; 8(1):51-62. PubMed ID: 6861794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
    Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
    Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and clearance of proxicromil--studies in rat, hamster, rabbit, dog, squirrel monkey, cynomolgus monkey, baboon and man.
    Smith DA; Neale MG
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):225-32. PubMed ID: 6653614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potentiation by clofibride of the heparin-induced clearing reaction (intravascular hydrolysis of neutral lipids), in hyperlipemic rabbits].
    Elsair J; Marquie G; Drif M; Khelfat K; Benouniche N; Tabet Aoul M; Tabet Aoul FS; Iklef F; Ghouini A
    C R Seances Soc Biol Fil; 1982; 176(2):140-5. PubMed ID: 6212098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.